Trading Analysis Report: AMC
- Analysis date: 2026-05-31
- Processed decision: Hold
- Price Target: $1.75
I. Analyst Team Reports
Market Analyst
Market Analyst
Investment Snapshot
| Metric | Latest value | Why it matters |
|---|---|---|
| NYSE close (May 29, 2026) | $1.73 | Entry price for the rating and target. |
| Previous close | $1.58 | Shares jumped sharply in the latest session. |
| Day range | $1.55-$1.79 | Intraday volatility remains high. |
| 52-week range | $0.93-$3.60 | Stock is above the low but far below the high. |
| 50-day / 200-day averages | $1.41 / $1.95 | Short-term momentum improved but long-term trend is weak. |
| Market cap / enterprise value | $1.30B / $8.65B | Debt dominates enterprise value. |
| Forward P/E | Negative | Consensus still implies losses. |
| Beta | 2.33 | Meme-stock volatility remains high. |
| Total revenue, market snapshot | $5.03B | AMC still has meaningful theatre revenue scale. |
| Total debt / cash | $7.93B / $339M | Liquidity and refinancing remain central risks. |
| Q1 2026 revenue | Above $1B | Revenue improved about 21% year over year. |
| Q1 2026 attendance | 47.6M guests | Attendance improved 13.6% year over year. |
| Q1 2026 net loss | -$117.1M | The company is still unprofitable. |
| Q1 adjusted EBITDA | $38.3M | Best first-quarter adjusted EBITDA since 2019. |
| 2026 capex guidance | $175M-$225M | Cash demands remain meaningful. |
| Analyst target mean / median | $1.95 / $1.75 | Median target is close to the current price. |
| Social mention rank | #13, 21 mentions | Retail attention rose sharply from a low base. |
AMC closed at $1.73 on May 29, 2026, up from $1.58 the prior session. The stock is above the 50-day average but still below the 200-day average, which is consistent with a speculative bounce rather than a confirmed long-term trend reversal.
The recovery case has improved. Q1 revenue was back above $1 billion, attendance rose, and adjusted EBITDA improved to the best first-quarter level since 2019. Those are genuine operating positives.
The rating is Hold with a $1.75 target. The target is close to the analyst median because upside from a better box office is offset by debt, negative earnings, dilution risk, and high volatility.
Sentiment Analyst
Sentiment Analyst
AMC ranked thirteenth in the StockNote missing-research queue with 21 mentions and 47 upvotes. The mention rank jumped from 122 twenty-four hours earlier to 21, showing a rapid return of retail attention.
The positive sentiment case is familiar: AMC remains a high-recognition meme stock, and any sign of box-office recovery or EBITDA improvement can quickly revive trading interest. The latest Q1 results give bulls something tangible to discuss.
The sentiment risk is equally familiar. AMC's retail following can create sharp rallies, but the underlying equity is still burdened by debt, negative profitability, potential dilution, and film-slate cyclicality. Sentiment can be powerful, but it is not the same as balance-sheet repair.
News Analyst
News Analyst
AMC's Q1 2026 results showed a meaningful operating rebound. Revenue exceeded $1 billion and increased about 21% year over year. Attendance was 47.6 million guests, up 13.6% year over year.
Adjusted EBITDA was $38.3 million, improving by about $96 million year over year and representing the company's best first-quarter adjusted EBITDA result since 2019. That suggests operating leverage can still work when box-office volume improves.
However, AMC remained unprofitable. Q1 net loss was $117.1 million, or $(0.36) per share. Cash and cash equivalents were $339.2 million at March 31, 2026, excluding restricted cash of $41.7 million, and Q1 free cash flow was negative in the earnings materials and related filing summaries.
Sources: AMC investor financial results page; AMC Q1 2026 earnings materials and Form 8-K; AMC 2025 Form 10-K; yfinance market snapshot retrieved May 31, 2026 for the May 29, 2026 NYSE close.
Fundamentals Analyst
Fundamentals Analyst
AMC is a theatrical exhibition company. The business depends on box-office volume, concession spending, premium formats, studio film release cadence, consumer discretionary demand, theatre leases, and financing availability.
The fundamental positive is operating leverage. A stronger film slate can lift attendance, food and beverage revenue, and adjusted EBITDA quickly. Q1 2026 showed that the business can improve meaningfully when attendance and revenue recover.
The fundamental negative is the balance sheet. The market snapshot shows $7.93 billion of debt versus only $339 million of cash and a market capitalization of about $1.30 billion. That capital structure means equity value is highly sensitive to refinancing, dilution, and cash burn.
II. Research Team Decision
Bull Researcher
Bull Case
The bull case is that AMC is no longer purely a distress story. Revenue exceeded $1 billion in Q1 2026, attendance grew 13.6%, and adjusted EBITDA improved by roughly $96 million year over year. If the 2026 film slate continues to strengthen, operating leverage can keep improving.
AMC also retains brand recognition and retail trading interest. The stock can move quickly when investor attention returns, as the latest move above the 50-day average shows.
A hold rating still leaves room for optionality. If box-office demand continues to recover and management reduces near-term refinancing risk without heavy dilution, the equity can justify a higher target.
Bear Researcher
Bear Case
The bear case is that the equity remains structurally risky. AMC is still unprofitable, carries high debt, has limited cash relative to obligations, and has a history of equity issuance and dilution.
The stock's enterprise value is much larger than its market capitalization, so small changes in debt value, refinancing terms, or cash flow expectations can have an outsized impact on equity. A negative forward P/E also shows that earnings recovery is not yet established.
The stock is below its 200-day average and far below the 52-week high. That means the recent rally is still speculative unless followed by sustained cash flow improvement.
Research Manager
Research Manager Decision
The balanced decision is Hold. AMC's Q1 operating improvement is real, but the equity risk remains too high for an Overweight rating.
Price Target: $1.75
The $1.75 target aligns with the analyst median and current trading range. The rating could improve if AMC produces sustained positive free cash flow and reduces debt without major dilution. It would weaken if box-office momentum fades, refinancing costs rise, or new equity issuance materially dilutes shareholders.
III. Trading Team Plan
Trader
Trading Plan
Rating: Hold
Price Target: $1.75
Time Horizon: 3-9 months
Investment Snapshot
| Metric | Latest value | Why it matters |
|---|---|---|
| NYSE close (May 29, 2026) | $1.73 | Entry price for the rating and target. |
| Previous close | $1.58 | Shares jumped sharply in the latest session. |
| Day range | $1.55-$1.79 | Intraday volatility remains high. |
| 52-week range | $0.93-$3.60 | Stock is above the low but far below the high. |
| 50-day / 200-day averages | $1.41 / $1.95 | Short-term momentum improved but long-term trend is weak. |
| Market cap / enterprise value | $1.30B / $8.65B | Debt dominates enterprise value. |
| Forward P/E | Negative | Consensus still implies losses. |
| Beta | 2.33 | Meme-stock volatility remains high. |
| Total revenue, market snapshot | $5.03B | AMC still has meaningful theatre revenue scale. |
| Total debt / cash | $7.93B / $339M | Liquidity and refinancing remain central risks. |
| Q1 2026 revenue | Above $1B | Revenue improved about 21% year over year. |
| Q1 2026 attendance | 47.6M guests | Attendance improved 13.6% year over year. |
| Q1 2026 net loss | -$117.1M | The company is still unprofitable. |
| Q1 adjusted EBITDA | $38.3M | Best first-quarter adjusted EBITDA since 2019. |
| 2026 capex guidance | $175M-$225M | Cash demands remain meaningful. |
| Analyst target mean / median | $1.95 / $1.75 | Median target is close to the current price. |
| Social mention rank | #13, 21 mentions | Retail attention rose sharply from a low base. |
AMC is a trading-oriented stock, not a clean long-term compounder at this stage. The move above the 50-day average improves short-term momentum, but the 200-day average near $1.95 remains a key resistance area.
Existing speculative holders can hold while monitoring whether price can sustain above $1.75 and challenge the 200-day average. New capital should wait for either a pullback or clearer evidence that Q1 improvement can become recurring cash flow.
Key signals are domestic box office, attendance, food and beverage spend per patron, adjusted EBITDA, free cash flow, debt exchanges, equity issuance, and retail sentiment spikes.
IV. Risk Management Team Decision
Aggressive Analyst
Aggressive Risk View
An aggressive investor can trade AMC momentum, but should recognize that this is not a balance-sheet-safe recovery. The stock can rally sharply on sentiment, short interest, and box-office headlines.
The aggressive setup improves if AMC breaks above the 200-day average and Q2 data confirm continued attendance recovery. A stronger film slate could drive another EBITDA step-up.
The risk is sudden dilution or refinancing pressure. Aggressive traders need defined stop levels because fundamentals can reassert quickly after sentiment-driven rallies.
Conservative Analyst
Conservative Risk View
A conservative investor should avoid treating AMC as a normal value stock. The low share price does not make the equity cheap when enterprise value is dominated by debt.
The conservative stance is to wait for sustained positive free cash flow, lower debt, and reduced dilution risk. Until then, the equity remains speculative.
Conservative portfolios should only hold AMC as a small, explicitly speculative position, if at all.
Neutral Analyst
Neutral Risk View
The neutral view supports Hold. AMC has improved enough to avoid a bearish rating, but not enough to earn a positive risk-adjusted rating.
A $1.75 target is appropriate because it reflects current median analyst expectations and recognizes both the improved EBITDA trajectory and the still-heavy debt burden.
Risk should be reviewed after each box-office and quarterly update. Sustained cash generation can improve the thesis; renewed cash burn or dilution would quickly weaken it.
V. Portfolio Manager Decision
Portfolio Manager
Portfolio Manager Decision
Final Rating: Hold
Price Target: $1.75
Time Horizon: 3-9 months
Investment Snapshot
| Metric | Latest value | Why it matters |
|---|---|---|
| NYSE close (May 29, 2026) | $1.73 | Entry price for the rating and target. |
| Previous close | $1.58 | Shares jumped sharply in the latest session. |
| Day range | $1.55-$1.79 | Intraday volatility remains high. |
| 52-week range | $0.93-$3.60 | Stock is above the low but far below the high. |
| 50-day / 200-day averages | $1.41 / $1.95 | Short-term momentum improved but long-term trend is weak. |
| Market cap / enterprise value | $1.30B / $8.65B | Debt dominates enterprise value. |
| Forward P/E | Negative | Consensus still implies losses. |
| Beta | 2.33 | Meme-stock volatility remains high. |
| Total revenue, market snapshot | $5.03B | AMC still has meaningful theatre revenue scale. |
| Total debt / cash | $7.93B / $339M | Liquidity and refinancing remain central risks. |
| Q1 2026 revenue | Above $1B | Revenue improved about 21% year over year. |
| Q1 2026 attendance | 47.6M guests | Attendance improved 13.6% year over year. |
| Q1 2026 net loss | -$117.1M | The company is still unprofitable. |
| Q1 adjusted EBITDA | $38.3M | Best first-quarter adjusted EBITDA since 2019. |
| 2026 capex guidance | $175M-$225M | Cash demands remain meaningful. |
| Analyst target mean / median | $1.95 / $1.75 | Median target is close to the current price. |
| Social mention rank | #13, 21 mentions | Retail attention rose sharply from a low base. |
The portfolio decision is Hold. AMC's Q1 2026 results show real improvement: revenue above $1 billion, attendance up 13.6%, and the best first-quarter adjusted EBITDA since 2019. That deserves recognition.
The reason not to rate the stock Overweight is the capital structure. Debt remains high, cash is limited, free cash flow is still a concern, and equity dilution risk remains part of the investment case. AMC can trade strongly, but the balance sheet limits conviction.
Maintain only speculative exposure. A sustained move above the 200-day average and evidence of recurring free cash flow would support a more constructive view. Without that, $1.75 is a fair near-term target.